Semaglutide/GLP-1 can also affect your bodys response to insulin and insulin-releasing medications, so your dosages may need to be adjusted to reduce your risk of hypoglycemia
The results originate from a double-blind, placebo-controlled clinical trial
Furthermore, among those already with a SUD, GLP-1s appeared to lower hospitalizations, overdoses, and death, GLP-1 receptor agonists are not replacements for current medication treatments for AUDbut may soon become important additions
I follow a lot of body positive accounts and people that are advocates for the plus-sized community, she said
The decision to continue, modify, or cease treatment should be made collaboratively between patient and prescriber, weighing individual benefits against adverse effects whilst considering alternative weight management strategies
For older adults Aging affects skin thickness, subcutaneous tissue distribution, and healing capacity